Stockscreener 앱 받기
3.80
16.30%
-0.74
시장 영업 전:
3.91
0.11
+2.89%
Outset Medical Inc 주식(OM)의 최신 뉴스
BTIG Lowers Price Target for Outset Medical (OM) to $15, Maintai - GuruFocus
Outset Medical stock dips on Q4 EPS miss - MassDevice
What’s the fair value of Outset Medical Inc. stockJuly 2025 Spike Watch & Verified Swing Trading Watchlists - mfd.ru
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strate - GuruFocus
Outset Medical: Stabilizing Execution, Improving Margins, and Balanced 2026 Outlook Support Buy Rating Despite Lower Target - TipRanks
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth By Investing.com - Investing.com India
Outset Medical (OM) Sets 2026 Revenue and Margin Targets - GuruFocus
Outset Medical Q4 Earnings Call Highlights - Yahoo Finance
Outset Medical earnings missed by $0.60, revenue fell short of estimates - Investing.com Canada
OM: Revenue up 5% to $119.5M, margin expands, and next-gen Tablo FDA-cleared for 2026 growth - TradingView
Earnings call transcript: Outset Medical Q4 2025 reports revenue growth - Investing.com
Outset Medical Inc. (OM) Misses Q4 EPS by 60c - StreetInsider
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Outset Medical Q4 Earnings Report: What Investors Need to Know - Benzinga
Dialysis device maker Outset cuts 2025 loss to $81.7M, gets FDA clearance - Stock Titan
Fund Flows: Can Outset Medical Inc sustain earnings growth2025 Valuation Update & Verified Technical Trade Signals - baoquankhu1.vn
Outset Medical Q4 2025 earnings preview - MSN
Outset Medical Inc (OM) Q4 2025: Everything You Need To Know Ahe - GuruFocus
Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating - Finviz
Stifel lowers price target on Outset Medical, Inc. (OM) to $8, maintains buy rating - MSN
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Outset Medical Secures Key FDA Clearance for Next-Generation Dialysis System - AD HOC NEWS
Outset Medical (NASDAQ:OM) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Held Back By Insufficient Growth Even After Shares Climb 35% - simplywall.st
Is Outset Medical Inc benefiting from innovation trendsJuly 2025 Retail & Expert Approved Momentum Ideas - baoquankhu1.vn
Outset Medical (NASDAQ:OM) Rating Increased to Hold at Wall Street Zen - MarketBeat
What are the future prospects of Outset Medical Inc.Weekly Earnings Recap & Reliable Momentum Entry Alerts - mfd.ru
Outset Medical, Inc. (OM) Investor Outlook: Is A 133.83% Upside On The Horizon? - DirectorsTalk Interviews
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - sharewise.com
Quarterly Earnings: What is Outset Medical Incs 5 year growth outlookMarket Activity Summary & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Guidance Update: Is Outset Medical Inc being accumulated by smart moneyJuly 2025 Volume & Long-Term Safe Investment Plans - baoquankhu1.vn
Outset Medical secures FDA clearance for Tablo haemodialysis system - Yahoo Finance
Outset Medical stock jumps after FDA clears next-gen Tablo platform - Investing.com Australia
Is Outset Medical Inc. stock risky to hold nowQuarterly Portfolio Report & Long-Term Growth Stock Strategies - mfd.ru
Outset Medical Gets FDA Clearance for Tablo Hemodialysis System - marketscreener.com
Outset Medical wins FDA nod for next-gen Tablo hemodialysis system - MassDevice
Outset Medical, Inc. Announces 510(K) Clearance by the U.S. Food and Drug Administration of Its Next-Generation Tablo Platform - marketscreener.com
Outset Medical Secures FDA Clearance For Next-Generation Tablo Hemodialysis System - Nasdaq
Outset Medical (OM) Gains FDA Clearance for Advanced Tablo Platf - GuruFocus
Outset Medical’s Tablo dialysis system meets FDA cybersecurity standards - Investing.com
Outset Medical Wins FDA Clearance for Next-Gen Tablo System - TipRanks
Outset Medical stock jumps after FDA clears next-gen Tablo platform By Investing.com - Investing.com Australia
Outset Medical rises after FDA clears upgraded dialysis system - TradingView
Outset Medical, Inc. Announces FDA Clearance for Next-Gen Tablo Platform - TradingView
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned - The Manila Times
Outset Medical receives FDA clearance for next-generation Tablo dialysis system - StreetInsider
Outset Medical’s Tablo dialysis system meets FDA cybersecurity standards By Investing.com - Investing.com Nigeria
Outset Medical, Inc. to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 11, 2026 - Quiver Quantitative
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 - The Manila Times
Dialysis device maker Outset Medical sets Feb. 11 results call - stocktitan.net
Will Outset Medical Inc benefit from geopolitical trends2025 Sector Review & Technical Pattern Based Buy Signals - baoquankhu1.vn
Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Earnings Beat: Is Outset Medical Inc stock risky to hold now2025 Price Momentum & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Don't Ignore The Insider Selling In Outset Medical - Sahm
Aug Levels: Will Outset Medical Inc face regulatory challenges2025 Technical Patterns & Weekly Stock Performance Updates - baoquankhu1.vn
Outset Medical, Inc. (OM): Investor Outlook With A Promising 125.96% Potential Upside - DirectorsTalk Interviews
0.45%
0.31%
자본화:
|
볼륨(24시간):